US5192528A
(en)
*
|
1985-05-22 |
1993-03-09 |
Liposome Technology, Inc. |
Corticosteroid inhalation treatment method
|
US5110806A
(en)
*
|
1985-06-26 |
1992-05-05 |
The Regents Of The University Of California |
Lung surfactant compositions
|
JP2770970B2
(ja)
*
|
1987-04-09 |
1998-07-02 |
フアイソンズ・ピーエルシー |
ペンタミジンを含有する医薬組成物
|
US5173303A
(en)
*
|
1989-05-25 |
1992-12-22 |
Technology Unlimited, Inc. |
Cutaneous delivery of organic materials
|
US6146657A
(en)
*
|
1989-12-22 |
2000-11-14 |
Imarx Pharmaceutical Corp. |
Gas-filled lipid spheres for use in diagnostic and therapeutic applications
|
US5773024A
(en)
*
|
1989-12-22 |
1998-06-30 |
Imarx Pharmaceutical Corp. |
Container with multi-phase composition for use in diagnostic and therapeutic applications
|
US5162361A
(en)
*
|
1990-04-10 |
1992-11-10 |
The United States Of America As Represented By The Secretary, Department Of Health And Human Services |
Method of treating diseases associated with elevated levels of interleukin 1
|
FR2664500B1
(fr)
*
|
1990-07-13 |
1994-10-28 |
Lille Ii Universite Droit Sant |
Procede de preparation d'une lipoproteine modifiee par incorporation d'une substance active lipophile, lipoproteine modifiee ainsi obtenue et composition pharmaceutique ou cosmetique la contenant.
|
JPH04356421A
(ja)
*
|
1991-03-06 |
1992-12-10 |
Green Cross Corp:The |
プロスタグランジン類含有脂肪小体組成物
|
US5993805A
(en)
*
|
1991-04-10 |
1999-11-30 |
Quadrant Healthcare (Uk) Limited |
Spray-dried microparticles and their use as therapeutic vehicles
|
US5272252A
(en)
*
|
1991-11-04 |
1993-12-21 |
Merrell Dow Pharmaceuticals Inc. |
Synthetic lung surfactant having antioxidant properties
|
DE4203306A1
(de)
*
|
1992-02-06 |
1993-08-12 |
Ig Spruehtechnik Gmbh |
Asthma oder pulmonal-aerosolzubereitungen mit lecithin
|
HUT67217A
(en)
*
|
1992-02-14 |
1995-03-28 |
Kaken Pharma Co Ltd |
Remedy for airway diseases
|
US6582728B1
(en)
*
|
1992-07-08 |
2003-06-24 |
Inhale Therapeutic Systems, Inc. |
Spray drying of macromolecules to produce inhaleable dry powders
|
WO1994007514A1
(en)
*
|
1992-09-29 |
1994-04-14 |
Inhale Therapeutic Systems |
Pulmonary delivery of active fragments of parathyroid hormone
|
US7448375B2
(en)
*
|
1993-01-29 |
2008-11-11 |
Aradigm Corporation |
Method of treating diabetes mellitus in a patient
|
US5915378A
(en)
*
|
1993-01-29 |
1999-06-29 |
Aradigm Corporation |
Creating an aerosolized formulation of insulin
|
US5743250A
(en)
|
1993-01-29 |
1998-04-28 |
Aradigm Corporation |
Insulin delivery enhanced by coached breathing
|
US6131567A
(en)
*
|
1993-01-29 |
2000-10-17 |
Aradigm Corporation |
Method of use of monomeric insulin as a means for improving the reproducibility of inhaled insulin
|
US5873358A
(en)
*
|
1993-01-29 |
1999-02-23 |
Aradigm Corporation |
Method of maintaining a diabetic patient's blood glucose level in a desired range
|
US5888477A
(en)
|
1993-01-29 |
1999-03-30 |
Aradigm Corporation |
Use of monomeric insulin as a means for improving the bioavailability of inhaled insulin
|
US5970973A
(en)
*
|
1993-01-29 |
1999-10-26 |
Aradigm Corporation |
Method of delivering insulin lispro
|
US6024090A
(en)
*
|
1993-01-29 |
2000-02-15 |
Aradigm Corporation |
Method of treating a diabetic patient by aerosolized administration of insulin lispro
|
US20010003739A1
(en)
*
|
1993-06-24 |
2001-06-14 |
Astrazeneca Ab |
Systemic administration of a therapeutic preparation
|
US5747445A
(en)
*
|
1993-06-24 |
1998-05-05 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
TW402506B
(en)
|
1993-06-24 |
2000-08-21 |
Astra Ab |
Therapeutic preparation for inhalation
|
US6794357B1
(en)
|
1993-06-24 |
2004-09-21 |
Astrazeneca Ab |
Compositions for inhalation
|
IS1796B
(is)
*
|
1993-06-24 |
2001-12-31 |
Ab Astra |
Fjölpeptíð lyfjablanda til innöndunar sem einnig inniheldur eykjaefnasamband
|
US6632456B1
(en)
*
|
1993-06-24 |
2003-10-14 |
Astrazeneca Ab |
Compositions for inhalation
|
US5830853A
(en)
|
1994-06-23 |
1998-11-03 |
Astra Aktiebolag |
Systemic administration of a therapeutic preparation
|
EP1462096B1
(en)
*
|
1994-03-07 |
2008-12-10 |
Nektar Therapeutics |
Methods and compositions for pulmonary delivery of insulin
|
US20030113273A1
(en)
*
|
1996-06-17 |
2003-06-19 |
Patton John S. |
Methods and compositions for pulmonary delivery of insulin
|
US5451569A
(en)
*
|
1994-04-19 |
1995-09-19 |
Hong Kong University Of Science And Technology R & D Corporation Limited |
Pulmonary drug delivery system
|
KR100384353B1
(ko)
*
|
1994-05-18 |
2003-10-04 |
네크타르 테라퓨틱스 |
인터페론의건조분말제형을제조하기위한방법및조성물
|
US6165976A
(en)
|
1994-06-23 |
2000-12-26 |
Astra Aktiebolag |
Therapeutic preparation for inhalation
|
US6290991B1
(en)
|
1994-12-02 |
2001-09-18 |
Quandrant Holdings Cambridge Limited |
Solid dose delivery vehicle and methods of making same
|
US6586006B2
(en)
|
1994-08-04 |
2003-07-01 |
Elan Drug Delivery Limited |
Solid delivery systems for controlled release of molecules incorporated therein and methods of making same
|
US5602110A
(en)
*
|
1994-08-31 |
1997-02-11 |
Case Western Reserve University |
Method and composition for treating cystic fibrosis
|
DE4434629C1
(de)
*
|
1994-09-28 |
1996-06-27 |
Byk Gulden Lomberg Chem Fab |
Zusammensetzungen zur Behandlung von IRDS und ARDS
|
US5508269A
(en)
*
|
1994-10-19 |
1996-04-16 |
Pathogenesis Corporation |
Aminoglycoside formulation for aerosolization
|
AU703532B2
(en)
*
|
1994-12-22 |
1999-03-25 |
Astra Aktiebolag |
Therapeutic preparation for inhalation containing parathyroid hormone, PTH
|
SK81197A3
(en)
|
1994-12-22 |
1997-11-05 |
Astra Ab |
Aerosol drug formulations, method for production thereof and its use
|
US6524557B1
(en)
|
1994-12-22 |
2003-02-25 |
Astrazeneca Ab |
Aerosol formulations of peptides and proteins
|
US5662929A
(en)
*
|
1994-12-23 |
1997-09-02 |
Universite De Montreal |
Therapeutic liposomal formulation
|
US6428771B1
(en)
*
|
1995-05-15 |
2002-08-06 |
Pharmaceutical Discovery Corporation |
Method for drug delivery to the pulmonary system
|
WO1997022333A1
(en)
*
|
1995-12-15 |
1997-06-26 |
National Research Council Of Canada |
Archaeosomes, archaeosomes containing coenzyme q10, and other types of liposomes containing coenzyme q10 as adjuvants and as delivery vehicles
|
US6083922A
(en)
*
|
1996-04-02 |
2000-07-04 |
Pathogenesis, Corp. |
Method and a tobramycin aerosol formulation for treatment prevention and containment of tuberculosis
|
US6020307A
(en)
*
|
1997-04-25 |
2000-02-01 |
Ony, Inc. |
Compositions and methods for isolating lung surfactant hydrophobic proteins SP-B and SP-C
|
US6214375B1
(en)
|
1996-07-16 |
2001-04-10 |
Generex Pharmaceuticals, Inc. |
Phospholipid formulations
|
US6517860B1
(en)
*
|
1996-12-31 |
2003-02-11 |
Quadrant Holdings Cambridge, Ltd. |
Methods and compositions for improved bioavailability of bioactive agents for mucosal delivery
|
ES2159938T3
(es)
*
|
1997-02-11 |
2001-10-16 |
Mse Pharmazeutika Gmbh |
Preparados transdermicos, orales e intravenosos de 2,3-dimetoxi-5-metil-6-decaprenil-1,4-benzoquinona.
|
ATE336254T1
(de)
*
|
1997-02-17 |
2006-09-15 |
Altana Pharma Ag |
Zusammensetzungen zur behandlung von irds oder ards die 3-(calcopropylmethoxy)-n-(3,5-dichloro-4-pyridi yl)-4-(difluoromethoxy) benzamid und lungensurfactant enthalten
|
US20030035778A1
(en)
*
|
1997-07-14 |
2003-02-20 |
Robert Platz |
Methods and compositions for the dry powder formulation of interferon
|
US6565885B1
(en)
*
|
1997-09-29 |
2003-05-20 |
Inhale Therapeutic Systems, Inc. |
Methods of spray drying pharmaceutical compositions
|
US20060165606A1
(en)
|
1997-09-29 |
2006-07-27 |
Nektar Therapeutics |
Pulmonary delivery particles comprising water insoluble or crystalline active agents
|
US20020017295A1
(en)
*
|
2000-07-07 |
2002-02-14 |
Weers Jeffry G. |
Phospholipid-based powders for inhalation
|
US6309623B1
(en)
*
|
1997-09-29 |
2001-10-30 |
Inhale Therapeutic Systems, Inc. |
Stabilized preparations for use in metered dose inhalers
|
US6352722B1
(en)
|
1997-12-23 |
2002-03-05 |
Quadrant Holdings Cambridge Limited |
Derivatized carbohydrates, compositions comprised thereof and methods of use thereof
|
US20010003580A1
(en)
*
|
1998-01-14 |
2001-06-14 |
Poh K. Hui |
Preparation of a lipid blend and a phospholipid suspension containing the lipid blend
|
US6372720B1
(en)
*
|
1998-02-05 |
2002-04-16 |
Kenneth J. Longmuir |
Liposome fusion and delivery vehicle
|
KR100445146B1
(ko)
*
|
1998-05-27 |
2004-08-18 |
유로-셀띠끄 소시에떼 아노님 |
항염증용 제제, 특히 하부호흡기의 창상치료 촉진용 약제및/또는 소독 약제
|
US6858223B2
(en)
|
1998-06-23 |
2005-02-22 |
Altana Pharma Ag |
Compositions comprising phenylaminothiophenacetic acid derivatives for the treatment of acute or adult respiratory distress syndrome (ARDS) and infant respiratory distress syndrome (IRDS)
|
BR9915218A
(pt)
*
|
1998-11-18 |
2001-07-31 |
Childrens Hosp Medical Center |
Composição proteìna de fusão, lisozima recombinante e método de profilaxia ou tratamento terapêutico de infecção bacteriana em mamìfero
|
US6660715B2
(en)
|
1998-11-19 |
2003-12-09 |
Massachusetts Institute Of Technology |
Nonaqueous solutions and suspensions of macromolecules for pulmonary delivery
|
US6855549B1
(en)
|
1998-11-23 |
2005-02-15 |
The University Of Iowa Research Foundation |
Methods and compositions for increasing the infectivity of gene transfer vectors
|
GB9912639D0
(en)
*
|
1999-05-28 |
1999-07-28 |
Britannia Pharmaceuticals Ltd |
Improvements in and relating to treatment of respiratory conditions
|
US6294153B1
(en)
|
1998-12-21 |
2001-09-25 |
Generex Pharmaceuticals, Inc. |
Aerosol pharmaceutical formulation for pulmonary and nasal delivery
|
US6350432B1
(en)
|
1999-03-19 |
2002-02-26 |
Generex Pharmaceuticals Incorporated |
Pressurized container having an aerosolized pharmaceutical composition
|
US6613352B2
(en)
|
1999-04-13 |
2003-09-02 |
Universite De Montreal |
Low-rigidity liposomal formulation
|
US7300667B1
(en)
|
1999-05-27 |
2007-11-27 |
Euro-Celtique, S.A. |
Preparations for the application of anti-inflammatory, especially antiseptic agents and/or agents promoting the healing of wounds, to the lower respiratory tract
|
US9006175B2
(en)
|
1999-06-29 |
2015-04-14 |
Mannkind Corporation |
Potentiation of glucose elimination
|
DK1196430T3
(da)
*
|
1999-06-29 |
2012-05-21 |
Mannkind Corp |
Rensning og stabilisering af peptider og proteiner i farmaceutiske midler
|
US6576224B1
(en)
*
|
1999-07-06 |
2003-06-10 |
Sinuspharma, Inc. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
US20020061281A1
(en)
*
|
1999-07-06 |
2002-05-23 |
Osbakken Robert S. |
Aerosolized anti-infectives, anti-inflammatories, and decongestants for the treatment of sinusitis
|
WO2001019392A1
(en)
*
|
1999-09-16 |
2001-03-22 |
Byk Gulden Lomberg Chemische Fabrik Gmbh |
Combination of c1-inh and lung surfactant for the treatment of respiratory disorders
|
EP1233811A2
(en)
*
|
1999-11-12 |
2002-08-28 |
Leo Rubin |
Methods for treating cardiac arrest or pulmonary hypertension and compositions for use therein comprising vasoactive intestinal polypeptide and cardiac device for electrical and chemical regulation and methods of use
|
DE10012151A1
(de)
*
|
2000-03-13 |
2001-09-27 |
Gsf Forschungszentrum Umwelt |
Mittel zur Behandlung von Erkrankungen des Tracheo-Brochialtraktes, insbesondere der COPD
|
GB0007150D0
(en)
*
|
2000-03-24 |
2000-05-17 |
Lamellar Therapeutics Limited |
Immunotherapeutic methods and compositions
|
WO2001077328A1
(en)
*
|
2000-04-06 |
2001-10-18 |
Franco Wayne P |
Methods of using growth factors for treating heart disease
|
US7871598B1
(en)
*
|
2000-05-10 |
2011-01-18 |
Novartis Ag |
Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
|
US8404217B2
(en)
|
2000-05-10 |
2013-03-26 |
Novartis Ag |
Formulation for pulmonary administration of antifungal agents, and associated methods of manufacture and use
|
CA2382133C
(en)
|
2000-05-10 |
2010-11-23 |
Alliance Pharmaceutical Corporation |
Phospholipid-based powders for drug delivery
|
US7273847B2
(en)
*
|
2000-06-30 |
2007-09-25 |
Mccormack Jr Francis X |
Peptides with antioxidant and antimicrobial properties
|
AU2001280934A1
(en)
*
|
2000-07-28 |
2002-02-13 |
Alliance Pharmaceutical Corp. |
Methods and compositions to upregulate, redirect or limit immune responses to bioactive compounds
|
SI1273292T1
(en)
*
|
2001-07-02 |
2004-12-31 |
Chiesi Farmaceutici S.P.A. |
Optimised formulation of tobramycin for aerosolization
|
SI1458360T1
(sl)
|
2001-12-19 |
2011-08-31 |
Novartis Ag |
Pulmonalno dajanje aminoglikozidov
|
JP2005519129A
(ja)
*
|
2002-03-05 |
2005-06-30 |
クリーブランド ステート ユニバーシティー |
エアロゾル薬物送達のための凝集粒子
|
WO2003075890A1
(en)
*
|
2002-03-05 |
2003-09-18 |
Transave, Inc. |
Methods for entrapment of bioactive agent in a liposome or lipid complex
|
DE60318938T2
(de)
|
2002-03-20 |
2009-01-22 |
Mannkind Corp., Valencia |
Inhalationsgerät
|
DE10214983A1
(de)
*
|
2002-04-04 |
2004-04-08 |
TransMIT Gesellschaft für Technologietransfer mbH |
Vernebelbare Liposomen und ihre Verwendung zur pulmonalen Applikation von Wirkstoffen
|
ES2831305T3
(es)
*
|
2002-10-29 |
2021-06-08 |
Insmed Inc |
Liposomas que comprenden un aminoglucósido para el tratamiento de infecciones pulmonares
|
US7879351B2
(en)
*
|
2002-10-29 |
2011-02-01 |
Transave, Inc. |
High delivery rates for lipid based drug formulations, and methods of treatment thereof
|
US7718189B2
(en)
|
2002-10-29 |
2010-05-18 |
Transave, Inc. |
Sustained release of antiinfectives
|
GB0322448D0
(en)
*
|
2003-09-25 |
2003-10-29 |
Lamellar Therapeutics Ltd |
Using lamellar bodies to modify linear biological macro molecules
|
DE10347994A1
(de)
*
|
2003-10-15 |
2005-06-16 |
Pari GmbH Spezialisten für effektive Inhalation |
Wässrige Aerosol-Zubereitung
|
US7338171B2
(en)
*
|
2003-10-27 |
2008-03-04 |
Jen-Chuen Hsieh |
Method and apparatus for visual drive control
|
DE60331601D1
(de)
*
|
2003-12-18 |
2010-04-15 |
Univ Giessen Justus Liebig |
Neue chimärische plasminogenaktivatoren und deren pharmazeutische verwendung
|
WO2005067964A1
(en)
*
|
2004-01-12 |
2005-07-28 |
Mannkind Corporation |
A method of reducing serum proinsulin levels in type 2 diabetics
|
US20080248999A1
(en)
*
|
2007-04-04 |
2008-10-09 |
Biodel Inc. |
Amylin formulations
|
PL2319500T3
(pl)
*
|
2004-03-12 |
2013-05-31 |
Biodel Inc |
Szybko działające kompozycje do dostarczania leku
|
US20080090753A1
(en)
*
|
2004-03-12 |
2008-04-17 |
Biodel, Inc. |
Rapid Acting Injectable Insulin Compositions
|
WO2005115520A1
(en)
*
|
2004-05-20 |
2005-12-08 |
Discovery Laboratories, Inc. |
Methods , systems and devices for noninvasive pulmonary delivery
|
ES2385934T3
(es)
|
2004-08-20 |
2012-08-03 |
Mannkind Corporation |
Catálisis de la síntesis de dicetopiperazina.
|
EP2314298B1
(en)
|
2004-08-23 |
2015-05-27 |
MannKind Corporation |
Microparticles comprising diketopiperazine salts for drug delivery
|
JP2008519076A
(ja)
*
|
2004-11-02 |
2008-06-05 |
テルアビブ ユニバーシティ フューチャー テクノロジー デベロップメント エル.ピー. |
脂質化グリコサミノグリカン粒子中の水不溶性又は水難溶性薬物の処方、並びに診断及び治療のためのこれらの使用
|
US7582312B2
(en)
*
|
2004-11-15 |
2009-09-01 |
Discovery Laboratories, Inc. |
Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof
|
US7464012B2
(en)
*
|
2004-12-10 |
2008-12-09 |
L'air Liquide, Societe Anonyme A Directoire Et Conseil De Surveillance Pour L'etude Et L'exploitation Des Procedes Georges Claude |
Simplified process simulator
|
US8337815B2
(en)
|
2004-12-23 |
2012-12-25 |
Discovery Laboratories, Inc. |
Pulmonary surfactant formulations
|
JP4744533B2
(ja)
*
|
2004-12-30 |
2011-08-10 |
ドゥビエル カンパニー リミテッド |
噴霧乾燥高分子型コレクチン属タンパク質及びその製造方法
|
AU2006203978B2
(en)
|
2005-01-06 |
2011-11-03 |
Discovery Laboratories, Inc. |
Surfactant treatment regimen for treating or preventing bronchopulmonary dysplasia
|
US8028697B2
(en)
|
2005-04-28 |
2011-10-04 |
Trudell Medical International |
Ventilator circuit and method for the use thereof
|
US20070031342A1
(en)
*
|
2005-06-22 |
2007-02-08 |
Nektar Therapeutics |
Sustained release microparticles for pulmonary delivery
|
KR20160022404A
(ko)
|
2005-09-14 |
2016-02-29 |
맨카인드 코포레이션 |
활성제에 대한 결정질 미립자 표면의 친화력의 증가를 기반으로 하는 약물 제제화의 방법
|
US7713929B2
(en)
|
2006-04-12 |
2010-05-11 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
WO2007041481A1
(en)
*
|
2005-09-29 |
2007-04-12 |
Biodel, Inc. |
Rapid acting and prolonged acting insulin preparations
|
US8084420B2
(en)
*
|
2005-09-29 |
2011-12-27 |
Biodel Inc. |
Rapid acting and long acting insulin combination formulations
|
US7827042B2
(en)
*
|
2005-11-30 |
2010-11-02 |
The Invention Science Fund I, Inc |
Methods and systems related to transmission of nutraceutical associated information
|
US20080004905A1
(en)
*
|
2006-06-28 |
2008-01-03 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Methods and systems for analysis of nutraceutical associated components
|
US8297028B2
(en)
|
2006-06-14 |
2012-10-30 |
The Invention Science Fund I, Llc |
Individualized pharmaceutical selection and packaging
|
US20070289258A1
(en)
*
|
2006-06-14 |
2007-12-20 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Individualized pharmaceutical selection and packaging
|
US20080052114A1
(en)
*
|
2005-11-30 |
2008-02-28 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational systems and methods related to nutraceuticals
|
US20070124176A1
(en)
*
|
2005-11-30 |
2007-05-31 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational and/or control systems and methods related to nutraceutical agent selection and dosing
|
US20080103746A1
(en)
*
|
2005-11-30 |
2008-05-01 |
Searete Llc, A Limited Liability Corporation |
Systems and methods for pathogen detection and response
|
US20070124219A1
(en)
*
|
2005-11-30 |
2007-05-31 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational and/or control systems related to individualized nutraceutical selection and packaging
|
US20070174128A1
(en)
*
|
2005-11-30 |
2007-07-26 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
|
US10296720B2
(en)
|
2005-11-30 |
2019-05-21 |
Gearbox Llc |
Computational systems and methods related to nutraceuticals
|
US8340944B2
(en)
*
|
2005-11-30 |
2012-12-25 |
The Invention Science Fund I, Llc |
Computational and/or control systems and methods related to nutraceutical agent selection and dosing
|
US7927787B2
(en)
*
|
2006-06-28 |
2011-04-19 |
The Invention Science Fund I, Llc |
Methods and systems for analysis of nutraceutical associated components
|
US20080033763A1
(en)
*
|
2005-11-30 |
2008-02-07 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Methods and systems related to receiving nutraceutical associated information
|
US8000981B2
(en)
|
2005-11-30 |
2011-08-16 |
The Invention Science Fund I, Llc |
Methods and systems related to receiving nutraceutical associated information
|
US20110145009A1
(en)
*
|
2005-11-30 |
2011-06-16 |
Jung Edward K Y |
Methods and systems related to transmission of nutraceutical associatd information
|
US20070136092A1
(en)
*
|
2005-11-30 |
2007-06-14 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational and/or control systems related to individualized pharmaceutical and nutraceutical selection and packaging
|
US20080114577A1
(en)
*
|
2005-11-30 |
2008-05-15 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Computational methods and systems associated with nutraceutical related assays
|
US7974856B2
(en)
|
2005-11-30 |
2011-07-05 |
The Invention Science Fund I, Llc |
Computational systems and methods related to nutraceuticals
|
DE102006051512A1
(de)
*
|
2005-12-06 |
2007-06-14 |
Pari GmbH Spezialisten für effektive Inhalation |
Pharmazeutische Medikamentenzusammensetzungen mit Cyclosporin
|
EP3718532A1
(en)
|
2005-12-08 |
2020-10-07 |
Insmed Incorporated |
Lipid-based compositions of antiinfectives for treating pulmonary infections
|
MX2008010721A
(es)
|
2006-02-22 |
2008-09-01 |
Mannkind Corp |
Un metodo para mejorar las propiedades farmaceuticas de microparticulas que contienen dicetopiperazina y un agente activo.
|
AU2007238114B2
(en)
*
|
2006-04-12 |
2010-10-14 |
Biodel, Inc. |
Rapid acting and long acting insulin combination formulations
|
CA2663795A1
(en)
*
|
2006-09-19 |
2008-03-27 |
Discovery Laboratories, Inc. |
Pulmonary surfactant formulations and methods for promoting mucus clearance
|
US8119156B2
(en)
*
|
2006-10-24 |
2012-02-21 |
Aradigm Corporation |
Dual action, inhaled formulations providing both an immediate and sustained release profile
|
US8268347B1
(en)
|
2006-10-24 |
2012-09-18 |
Aradigm Corporation |
Dual action, inhaled formulations providing both an immediate and sustained release profile
|
US8071127B2
(en)
*
|
2006-10-24 |
2011-12-06 |
Aradigm Corporation |
Dual action, inhaled formulations providing both an immediate and sustained release profile
|
WO2008121811A2
(en)
|
2007-03-29 |
2008-10-09 |
National Jewish Medical And Research Center |
Surfactant lipids, compositions thereof, and uses thereof
|
TW200902085A
(en)
|
2007-03-30 |
2009-01-16 |
Hirofumi Takeuchi |
Liposome for pulmonary administration to control drug delivery
|
US20100196455A1
(en)
*
|
2007-05-04 |
2010-08-05 |
Transave, Inc. |
Compositions of Multicationic Drugs for Reducing Interactions with Polyanionic Biomolecules and Methods of Use Thereof
|
US9114081B2
(en)
|
2007-05-07 |
2015-08-25 |
Insmed Incorporated |
Methods of treating pulmonary disorders with liposomal amikacin formulations
|
US9119783B2
(en)
|
2007-05-07 |
2015-09-01 |
Insmed Incorporated |
Method of treating pulmonary disorders with liposomal amikacin formulations
|
US9333214B2
(en)
|
2007-05-07 |
2016-05-10 |
Insmed Incorporated |
Method for treating pulmonary disorders with liposomal amikacin formulations
|
CN101754747A
(zh)
*
|
2007-06-05 |
2010-06-23 |
Paka肺部医药公司 |
用于向肺脏递送药物的方法以及组合物
|
JP5352596B2
(ja)
*
|
2008-01-04 |
2013-11-27 |
バイオデル, インコーポレイテッド |
組織グルコースレベルの関数としてのインスリン放出のためのインスリン製剤
|
SI2265309T1
(sl)
|
2008-03-17 |
2016-04-29 |
Discovery Laboratories, Inc. |
Adapter za cevje ventilatorja in sistem za proksimalno dovajanje aerosola
|
EP3281663B8
(en)
|
2008-06-13 |
2022-09-21 |
MannKind Corporation |
Breath powered dry powder inhaler for drug delivery
|
US8485180B2
(en)
|
2008-06-13 |
2013-07-16 |
Mannkind Corporation |
Dry powder drug delivery system
|
MX2010014240A
(es)
|
2008-06-20 |
2011-03-25 |
Mankind Corp |
Un metodo y aparato interactivo para perfilar en tiempo real esfuerzos de inhalacion.
|
TWI614024B
(zh)
|
2008-08-11 |
2018-02-11 |
曼凱公司 |
超快起作用胰島素之用途
|
ES2402241T3
(es)
|
2008-10-22 |
2013-04-30 |
Trudell Medical International |
Sistema de suministro de aerosol modular
|
CN102271666A
(zh)
|
2008-12-10 |
2011-12-07 |
Paka肺部医药公司 |
用于向肺脏递送药物的方法和组合物
|
US8314106B2
(en)
|
2008-12-29 |
2012-11-20 |
Mannkind Corporation |
Substituted diketopiperazine analogs for use as drug delivery agents
|
US9060927B2
(en)
*
|
2009-03-03 |
2015-06-23 |
Biodel Inc. |
Insulin formulations for rapid uptake
|
CA2754595C
(en)
|
2009-03-11 |
2017-06-27 |
Mannkind Corporation |
Apparatus, system and method for measuring resistance of an inhaler
|
US8551528B2
(en)
|
2009-06-12 |
2013-10-08 |
Mannkind Corporation |
Diketopiperazine microparticles with defined specific surface areas
|
DE102009031274A1
(de)
|
2009-06-30 |
2011-01-13 |
Justus-Liebig-Universität Giessen |
Liposomen zur pulmonalen Applikation
|
EP2496295A1
(en)
|
2009-11-03 |
2012-09-12 |
MannKind Corporation |
An apparatus and method for simulating inhalation efforts
|
BR112012033060A2
(pt)
|
2010-06-21 |
2018-02-27 |
Mannkind Corp |
métodos de sistema de liberação de fármaco em pó seco
|
KR101940832B1
(ko)
|
2011-04-01 |
2019-01-21 |
맨카인드 코포레이션 |
의약 카트리지용 블리스터 패키지
|
WO2012174472A1
(en)
|
2011-06-17 |
2012-12-20 |
Mannkind Corporation |
High capacity diketopiperazine microparticles
|
EP2776053A1
(en)
|
2011-10-24 |
2014-09-17 |
MannKind Corporation |
Methods and compositions for treating pain
|
WO2013188016A2
(en)
|
2012-05-04 |
2013-12-19 |
Discovery Laboratories, Inc. |
Surfactant therapy for exposure to ionizing radiation
|
EP2852391B1
(en)
|
2012-05-21 |
2021-11-17 |
Insmed Incorporated |
Systems for treating pulmonary infections
|
SG11201500218VA
(en)
|
2012-07-12 |
2015-03-30 |
Mannkind Corp |
Dry powder drug delivery systems and methods
|
EP2911690A1
(en)
|
2012-10-26 |
2015-09-02 |
MannKind Corporation |
Inhalable influenza vaccine compositions and methods
|
RU2018135921A
(ru)
|
2012-11-29 |
2019-02-05 |
Инсмед Инкорпорейтед |
Стабилизированные составы ванкомицина
|
EP3587404B1
(en)
|
2013-03-15 |
2022-07-13 |
MannKind Corporation |
Microcrystalline diketopiperazine compositions, methods for preparation and use thereof
|
BR122019026637B1
(pt)
|
2013-07-18 |
2023-09-26 |
Mannkind Corporation |
Formulações farmacêuticas de pó seco e método para a fabricação de uma formulação de pó seco
|
CA2920488C
(en)
|
2013-08-05 |
2022-04-26 |
Mannkind Corporation |
Insufflation apparatus and methods
|
WO2015042170A1
(en)
|
2013-09-17 |
2015-03-26 |
Wayne State University |
Compositions and uses of combinations of dim-related indoles and selected anti-androgen compounds
|
AU2014340568B2
(en)
|
2013-10-22 |
2017-02-02 |
Aradigm Corporation |
Inhaled surfactant-modified liposomal formulations providing both an immediate and sustained release profile
|
WO2015148905A1
(en)
|
2014-03-28 |
2015-10-01 |
Mannkind Corporation |
Use of ultrarapid acting insulin
|
ES2755941T3
(es)
|
2014-05-15 |
2020-04-24 |
Insmed Inc |
Métodos para tratar infecciones pulmonares micobacterianas no tuberculosas
|
US10561806B2
(en)
|
2014-10-02 |
2020-02-18 |
Mannkind Corporation |
Mouthpiece cover for an inhaler
|
WO2019191627A1
(en)
|
2018-03-30 |
2019-10-03 |
Insmed Incorporated |
Methods for continuous manufacture of liposomal drug products
|
JP2021530492A
(ja)
*
|
2018-07-12 |
2021-11-11 |
ザ ユナイテッド ステイツ オブ アメリカ, アズ リプレゼンテッド バイ ザ セクレタリー, デパートメント オブ ヘルス アンド ヒューマン サービシーズ |
包埋された細胞傷害剤を含む二成分脂質二重層含有ベシクル、ならびにそれを作製および使用する方法
|